About 6,950 feather mites were isolated from filed collections and examination of bird study skins at the zoological specimen room of Kon-Kuk University in Seoul. Among them, 3 species of Kramerellidae, Dermonoton longiventer (Megnin & Trouessart, 1884), Kramerella bubonis (Lonnfors, 1937), Neopetitota bubonis Atyeo & Philips, 1984, and 1 species of Pterolichidae, Epopolichus atelus Gaud, 1981, were newly recorded from Korea. They were redescribed with their new hosts.
parasitoloyg-arthropoda ; Acari ; Pterolichoidea ; Kramerellidae ; Dermonoton longiventer ; Kramerella bubonis ; Neopetitota bubnis ; Pterolichidae ; Epopolichus atelus

No abstract available.
Thyroid Gland*

BACKGROUND: Self-expandable metallic stent is an effective method in palliative treatment of malignant biliary stricture. However, it is controvesial in benign biliary stricture due to recurrent jaundice, cholangtitis, and finally, obstruction of stent. The purpose of this study was to determine the long-term effectiveness of Gianturco expandable metallic stents in benign biliary strictures. METHODS: We inserted Gianturco self-expandable metallic stent in 13 patients (42~69 years old, 6 men and 7 women) with benign biliary stricture between November 1991 and September 1994 in Wonkwang University Hospital. All patients had a previous history of biliary surgery and underwent balloon dilatation procedure for management of strictures. Insertion routes were percutaneous transhepatic biliary drainage tracks in 8 cases and T-tube tracks in 5 cases. The insertion site was the right intrahepatic duct in 5 cases, the left intrahepatic duct in 2 cases, both intrahepatic ducts in 1 case, common hepatic duct in 1 case, and distal common bile ducts in 4 cases. The stents used were 2~6cm in length and 8~12mm in diameter. The follow-up period was 46months to 81months(mean, 67months). RESULTS: The initial technical success rate was 100% with good immediate patency in all patients. Nine patients(69.2%) had no recurrence of the initial strictures during the follow-up period and 4 patients(30.7%) had further symptoms of biliary obstruction caused by recurrent cholangitis or intrahepatic duct stone formation. These 4 recurrent biliary strictures were treated by surgical methods. The recurrent stricture sites were distal common bile duct(1case), left intrahepatic duct(1case), both intrahepatic ducts(1case), and Roux-en-Y hepaticojejunostomy site(1case). CONCLUSIONS: According to the results of long-term follow-up, expandable metallic stent is a useful method in recurrent biliary strictures, especially in the case where operation is not feasible; poor risk patients, patients refusing operation, multiple biliary operation.
Bile ; Cholangitis ; Common Bile Duct ; Constriction, Pathologic* ; Dilatation ; Drainage ; Follow-Up Studies* ; Hepatic Duct, Common ; Humans ; Jaundice ; Male ; Palliative Care ; Recurrence ; Stents*

PURPOSE: We reported the CT and MR findings of 2 cases with Sturge-Weber syndrome which were not accompanied by facial nevi. MATERIALS AND METHODS: They were examined with both CT and MR in one case and with MR only in the other case. RESULTS: CT was better than MR in the demonstration of the characteristic cortical calcification. MR was superior to CT in the depiction of the abnormalities of the surrounding parenchyma and the intense enhancement of pial angiomatosis with Gd-DTPA enhancement. CONCLUSION: Gd-DTPA enhanced MR imaging could be useful in the demonstration of the presence and extent of pial angiomatosis in patients with suspected Sturge-Weber syndrome.
Angiomatosis ; Gadolinium DTPA ; Humans ; Magnetic Resonance Imaging ; Nevus* ; Sturge-Weber Syndrome*

The use of atypical antipsychotics is limited by occurrence of adverse reactions such as weight gain, despite of their benefits. This article provides a comprehensive review and discussion of the most significant findings regarding obesity-related pathways and integrates these with the known mechanism of atypical antipsychotic action. The focus of this article is primarily on the genetics of obesity related pathways that may be disrupted by atypical antipsychotics. This review also discussed weight gain, hyperglycemia or occurrence of diabetes while being treated with atypical antipsychotics from the point of view of pharmacogenetics. Pharmacogenetic research seeks to uncover genetic factors that will help clinicians identify the best treatment strategies for their patients. It will aid clinically in the prediction of response and side effects, such as antipsychotic-induced weight gain, and minimize the current "trial and error" approach to prescribing in the near future. This article also presents the genetics of both central and peripheral pathways putatively involved in antipsychotic-induced weight gain while providing a comprehensive review of the obesity literature. This article also review obesity related candidate molecules which may be disrupted during atypical antipsychotic drug treatment.
Antipsychotic Agents ; Genetics ; Humans ; Hyperglycemia ; Obesity ; Pharmacogenetics* ; Weight Gain*

OBJECT: The goal of this study was to examine the changes in body weight and glucose levels of the patients treated with risperidone, clozapine or haloperidol in order to compare the effect of risperidone or clozapine with that of haloperidol. METHODS: For nine months(January to September, 2003), a prospective study was performed in 60 patients with chronic schizophrenia who were in Seoul National Hospital. Two-week period was required for a drug wash-out. The patients were randomly assigned to risperidone, clozapine and haloperidol groups. They were given risperidone(n=20), clozapine(n=20) and haloperidol(n=20), respectively, everyday for 12 weeks. To examine the effects of these drugs on body weight and fasting glucose levels, we measured body weight and glucose levels of all the patients first without the drug treatment and at each end of 4, 8, and 12-week periods with the treatment. And we examined the differences among three groups in the changes of body weight and fasting glucose levels. RESULTS: There were no significant differences in the changes of the body weight and fasting glucose levels between the atypical antipsychotics(risperidone or clozapine) and the typical antipsychotics(haloperidol). CONCLUSION: The study in the patients with chronic schizophrenia suggests that risperidone or clozapine do not cause any additional effects on body weight or glucose levels compared to haloperidol.
Body Weight* ; Clozapine* ; Fasting ; Glucose* ; Haloperidol* ; Humans ; Prospective Studies ; Risperidone* ; Schizophrenia* ; Seoul ; Weight Gain

No abstract available.
Angioplasty* ; Child* ; Humans ; Takayasu Arteritis*

No abstract available.
Gastric Stump*

PURPOSE: PET developed on the basis of biochemical characteristics of malignant tissues where the increase in glucose metabolism. Therefore, early and accurate detection of primary or metastatic lesion can be expected. This study is to compare PET and other traditional methods in detection of primary breast carcinoma and metastatic lesion, and to find the advantage of PET. MATERIALS AND METHODS: We compared and analysed the results of PET, US, mammogr aphy, bone scan, CT and biopsy reports of the 46 patients who were examined in our hospital from September 1, 19094 to July 31, 1995. PET Trace 200 cyclotron and PET Advanced Scenner were used for FDG synthesis and imaging respectively. RESULTS: 10 of the 12 cases who had preoperative PET were consistent with the results of mammography and ultrasound and 9 of the 10 cases were consistent with the pathologic results. In one case, which did mammography and PET after excis ional biopsy, PET gaves a false positive result. In the detection of axilliary node metastasis, PeT after excisional biopsy, PET gaves a false positive result. In the detection of axilliary node metastasis, PET shows 100% sensitivity and specificity but bone scan shows 100%, 72.2% respectively. CONCLUSION: PET is useful for diagnosis of primary breast cancer and is superior to bone scan in specificity for diagnosis of bone metastasis and in early detection of response to treatment. Because PET cannot exclude false (+) in inflamm atory lesion, continuous investigation is needed for establishment of indication and reduction of false (+), false (-).In spite of high cost, PET may become a new and useful diagnostic tool.
Biopsy ; Breast Neoplasms* ; Breast* ; Cyclotrons ; Diagnosis* ; Electrons* ; Glucose ; Humans ; Mammography ; Metabolism ; Neoplasm Metastasis ; Positron-Emission Tomography* ; Sensitivity and Specificity ; Ultrasonography

PURPOSE: Recently the percutaneous aspiration with sclerotherapy of the simple renal cyst are being widely used because of the high success rate and the low morbidity. However, studies concerning the long term result of this technique have been rarely reported. Thus, we performed this study to evaluate the long term results of this technique. MATERIALS AND METHODS: We evaluated the long term result of the treatment in 20 cases of simple renal cysts from July 1993 to July 1998. The symptoms associated with simple renal cysts were: none(55%), pain(35%) and palpable mass(10%). The simple renal cysts were treated with percutaneous aspiration and injection of 99% ethanol in 15 cases or percutaneous aspiration and injection of 10% tetracycline solution in 5 cases. All were followed by ultrasound from 18 to 58 months(mean 32.7 months). RESULTS: Complete collapse, partial collapse and recurrence of the renal cysts were 5/15(33.3%), 7/15(46.6%), 3/15(20%) in 99% ethanol group and 3/5(60%), 1/5(20%), 1/5(20%) in 10% tetracycline solution group, respectively. Overall efficacies were 80% in both groups. Furthermore, all recurrences occurred within the first year of follow up period in both groups. CONCLUSIONS: Therefore, percutaneous aspiration with sclerotherapy using 99% ethanol or 10% tetracycline solution seem to be an effective way to prevent re-accumulation of cystic fluid. It also proved to have a positive long term result concerning the relapse of the simple renal cyst.
Ethanol ; Follow-Up Studies* ; Recurrence ; Sclerotherapy* ; Tetracycline ; Ultrasonography